Lawrence S Nagle, MD | |
979 E 3rd St, Ste A0540-a0550, Chattanooga, TN 37403-2136 | |
(423) 752-5004 | |
(423) 756-9009 |
Full Name | Lawrence S Nagle |
---|---|
Gender | Male |
Speciality | Internal Medicine - Hematology & Oncology |
Location | 979 E 3rd St, Chattanooga, Tennessee |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811954977 | NPI | - | NPPES |
3083473 | Medicaid | TN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | MD0017696 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lawrence S Nagle, MD 979 E 3rd St, Ste A0540-a0550, Chattanooga, TN 37403-2136 Ph: (423) 752-5004 | Lawrence S Nagle, MD 979 E 3rd St, Ste A0540-a0550, Chattanooga, TN 37403-2136 Ph: (423) 752-5004 |
News Archive
The Universitat Jaume I (UJI) of Castelló is working on the early detection of Alzheimer's Disease by using functional magnetic resonance imaging (fMRI) techniques. The study is being carried out within the framework of a national project called MIND, which approaches Alzheimer's disease from a multidisciplinary perspective and involves twelve biomedicine companies and the corresponding public research organisations associated with them.
In collaboration with Rigshospitalet, researchers from DTU Health Technology have developed a machine learning model that can predict chemotherapy-associated nephrotoxicity, a particularly significant side effect in patients treated with cisplatin.
Electronic dating violence—including electronic harassment, coercion and monitoring—starts increasing in preadolescence but curves as teens reach young adulthood, according to a new University of Michigan study.
Amerigen Pharmaceuticals Limited today announced that the U.S. Food and Drug Administration has granted tentative approval to the Company's Abbreviated New Drug Application (ANDA) for a generic version of Toviaz (Fesoterodine Fumarate Extended-release Tablets, 4mg and 8mg).
› Verified 3 days ago
Dr. Pamela Rani Sud, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 725 Glenwood Drive, Suite E-500, Chattanooga, TN 37404 Phone: 423-495-2635 Fax: 423-495-2638 | |
David Shved, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-5179 Fax: 423-778-2108 | |
Megan J Coylewright, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-8258 | |
Dr. Charles Robert Bosshardt, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2515 Desales Ave Ste 206, Chattanooga, TN 37404 Phone: 423-698-8101 Fax: 423-698-3450 | |
Dr. Elise Helene Marshall, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 605 Glenwood Dr Ste 300, Chattanooga, TN 37404 Phone: 423-495-2690 Fax: 423-495-2698 | |
Dr. Joshua Warner Hornsby, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 979 E 3rd St Ste A-440, Chattanooga, TN 37403 Phone: 423-778-2867 Fax: 423-778-2866 | |
Dr. Donald Franklin Mackler, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 721 Glenwood Dr, Ste. W552, Chattanooga, TN 37404 Phone: 423-629-6258 Fax: 423-629-9531 |